These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

384 related items for PubMed ID: 9720741

  • 21. Low incidence of acute graft-versus-host disease and recurrent leukaemia in patients undergoing allogeneic haemopoietic stem cell transplantation from sibling donors with methotrexate and dose-monitored cyclosporin A prophylaxis.
    Byrne JL, Stainer C, Hyde H, Miflin G, Haynes AP, Bessell EM, Russell NH.
    Bone Marrow Transplant; 1998 Sep; 22(6):541-5. PubMed ID: 9758340
    [Abstract] [Full Text] [Related]

  • 22. Treatment with granulocyte colony-stimulating factor after allogeneic bone marrow transplantation for acute leukemia increases the risk of graft-versus-host disease and death: a study from the Acute Leukemia Working Party of the European Group for Blood and Marrow Transplantation.
    Ringdén O, Labopin M, Gorin NC, Le Blanc K, Rocha V, Gluckman E, Reiffers J, Arcese W, Vossen JM, Jouet JP, Cordonnier C, Frassoni F.
    J Clin Oncol; 2004 Feb 01; 22(3):416-23. PubMed ID: 14691124
    [Abstract] [Full Text] [Related]

  • 23. Allogeneic peripheral blood stem cell transplantation for leukemia.
    Zhu K, Xu Y, Wu D, Xu X, Huang L.
    Chin Med J (Engl); 2001 May 01; 114(5):493-6. PubMed ID: 11780411
    [Abstract] [Full Text] [Related]

  • 24. [Allogeneic hematopoietic transplantation with stem cells extracted from peripheral blood].
    Kusminsky G, Foncuberta MC, Aversa L, Drelichman G, Freigeiro D, Burgos R, Irrazabal C, Gonzalez G, Dictar M, Niborski R, Kohan A, Sanchez Avalos JC.
    Medicina (B Aires); 2000 May 01; 60(2):179-87. PubMed ID: 10962806
    [Abstract] [Full Text] [Related]

  • 25. Allogeneic peripheral blood stem cell transplantation for haematological malignancies--an analysis of kinetics of engraftment and GVHD risk.
    Miflin G, Russell NH, Hutchinson RM, Morgan G, Potter M, Pagliuca A, Marsh J, Bell A, Milligan D, Lumley M, Cook G, Franklin I.
    Bone Marrow Transplant; 1997 Jan 01; 19(1):9-13. PubMed ID: 9012925
    [Abstract] [Full Text] [Related]

  • 26. Low incidence of severe aGVHD and accelerating hemopoietic reconstitution in allo-BMT using lenograstim stimulated BM cells.
    Ji S, Chen H, Wang H, Ma J, Pan S, Xue M, Zhu L, Liu J, Xiao M, Zhou L.
    Chin Med J (Engl); 2001 Feb 01; 114(2):191-5. PubMed ID: 11780205
    [Abstract] [Full Text] [Related]

  • 27. Allogeneic transplantation of peripheral blood progenitor cells in children: experience of two pediatric centers.
    Miniero R, Busca A, Bonetti F, Giorgiani G, Zecca M, Berger M, Incarbone E, Vassallo E, Perotti C, Locatelli F.
    Bone Marrow Transplant; 1998 Dec 01; 22 Suppl 5():S33-6. PubMed ID: 9989887
    [Abstract] [Full Text] [Related]

  • 28. [Effects and prognostic factors of HLA-matched sibling donor allogeneic hematopoietic stem cell transplantation for chronic myelogenous leukemia].
    Tong XZ, Li J, Tan EX, Zhang GC, Wu XY, Peng AH, Zheng D, Zou WY, Hong WD, Luo SK.
    Zhonghua Zhong Liu Za Zhi; 2006 Jul 01; 28(7):545-8. PubMed ID: 17147125
    [Abstract] [Full Text] [Related]

  • 29. [A pilot study of G-CSF mobilized allogeneic bone marrow cells plus peripheral blood stem cells transplantation for malignant hematological diseases].
    Chen Y, Huang X, Xu L, Liu D, Zhang Y, Ren H, Guo N, Lu D.
    Zhonghua Yi Xue Za Zhi; 2002 Oct 10; 82(19):1306-9. PubMed ID: 12509932
    [Abstract] [Full Text] [Related]

  • 30. Matched-pair analysis comparing allogeneic PBPCT and BMT from HLA-identical relatives in childhood acute lymphoblastic leukemia.
    Vicent MG, Madero L, Ortega JJ, Martinez A, Gomez P, Verdeguer A, Badell I, Muñoz A, Olive T, Maldonado MS, Bureo E, Cubells J, Diaz MA, Spanish Working Party for BMT in Children (GETMON).
    Bone Marrow Transplant; 2002 Jul 10; 30(1):9-13. PubMed ID: 12105771
    [Abstract] [Full Text] [Related]

  • 31. Allogeneic stem cell transplantation after a fludarabine/busulfan-based reduced-intensity conditioning in patients with myelodysplastic syndrome or secondary acute myeloid leukemia.
    Kröger N, Bornhäuser M, Ehninger G, Schwerdtfeger R, Biersack H, Sayer HG, Wandt H, Schäfer-Eckardt K, Beyer J, Kiehl M, Zander AR, German Cooperative Transplant Study Group.
    Ann Hematol; 2003 Jun 10; 82(6):336-42. PubMed ID: 12728337
    [Abstract] [Full Text] [Related]

  • 32. Hematopoietic stem cell transplantation for high-risk adult patients with severe aplastic anemia; reduction of graft failure by enhancing stem cell dose.
    Min CK, Kim DW, Lee JW, Han CW, Min WS, Kim CC.
    Haematologica; 2001 Mar 10; 86(3):303-10. PubMed ID: 11255278
    [Abstract] [Full Text] [Related]

  • 33. A comparison of postengraftment infectious morbidity and mortality after allogeneic partially T cell-depleted peripheral blood progenitor cell transplantation versus T cell-depleted bone marrow transplantation.
    Broers AE, van der Holt B, Haze S, Braakman E, Gratama JW, Löwenberg B, Cornelissen JJ.
    Exp Hematol; 2005 Aug 10; 33(8):912-9. PubMed ID: 16038784
    [Abstract] [Full Text] [Related]

  • 34. Unrelated donor cord blood transplantation in adults with chronic myelogenous leukemia: results in nine patients from a single institution.
    Sanz GF, Saavedra S, Jiménez C, Senent L, Cervera J, Planelles D, Bolufer P, Larrea L, Martín G, Martínez J, Jarque I, Moscardó F, Plumé G, Andreu R, de la Rubia J, Barragán E, Solves P, Soler MA, Sanz MA.
    Bone Marrow Transplant; 2001 Apr 10; 27(7):693-701. PubMed ID: 11360108
    [Abstract] [Full Text] [Related]

  • 35. Standard versus alternative myeloablative conditioning regimens in allogeneic hematopoietic stem cell transplantation for high-risk acute leukemia.
    Mengarelli A, Iori A, Guglielmi C, Romano A, Cerretti R, Torromeo C, Micozzi A, Fenu S, Laurenti L, Donato V, De Felice L, Arcese W.
    Haematologica; 2002 Jan 10; 87(1):52-8. PubMed ID: 11801465
    [Abstract] [Full Text] [Related]

  • 36. A retrospective Dutch study comparing T cell-depleted allogeneic blood stem cell transplantation vs T cell-depleted allogeneic bone marrow transplantation.
    Cornelissen JJ, Fibbe WE, Schattenberg AV, Petersen EJ, Willemze R, de Witte TJ, Löwenberg B, Verdonck LF, vd Biezen A, Brand R.
    Bone Marrow Transplant; 1998 Jun 10; 21 Suppl 3():S66-70. PubMed ID: 9712499
    [Abstract] [Full Text] [Related]

  • 37. CD34+ stem cell augmentation of elutriated allogeneic bone marrow grafts: results of a phase II clinical trial of engraftment and graft-versus-host disease prophylaxis in high-risk hematologic malignancies.
    O'Donnell PV, Jones RJ, Vogelsang GB, Seber A, Ambinder RF, Flinn I, Miller C, Marcellus DC, Griffin C, Abrams R, Braine HG, Grever M, Hess AD, Piantadosi S, Noga SJ.
    Bone Marrow Transplant; 1998 Nov 10; 22(10):947-55. PubMed ID: 9849691
    [Abstract] [Full Text] [Related]

  • 38. Alloreactivity as therapeutic principle in the treatment of hematologic malignancies. Studies of clinical and immunologic aspects of allogeneic hematopoietic cell transplantation with nonmyeloablative conditioning.
    Petersen SL.
    Dan Med Bull; 2007 May 10; 54(2):112-39. PubMed ID: 17521527
    [Abstract] [Full Text] [Related]

  • 39. [Allogeneic peripheral blood stem cell transplantation in 30 patients with hematologic disorders].
    Sawada H, Morimoto H, Wake A, Yamasaki Y, Izumi Y, Kuroiwa M, Osabe S, Imamura Y, Egami K, Tsukamoto A, Sanada I, Kiyokawa T, Kawano F.
    Rinsho Ketsueki; 1998 Nov 10; 39(11):1085-91. PubMed ID: 9866419
    [Abstract] [Full Text] [Related]

  • 40. [Induction of aGVHD after allogeneic hematopoietic stem cell transplantation for refractory or relapsed acute leukemia].
    Sun J, Meng FY, Liu QF, Xu D, Xu B, Liu XL.
    Ai Zheng; 2003 Dec 10; 22(12):1321-4. PubMed ID: 14693060
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 20.